Filing Details
- Accession Number:
- 0001209191-20-020744
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2020-03-23 19:12:29
- Reporting Period:
- 2019-09-24
- Accepted Time:
- 2020-03-23 19:12:29
- Original Submission Date:
- 2019-09-26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1610618 | Cidara Therapeutics Inc. | CDTX | () | 4/A |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1463151 | E. James Levine | C/O Cidara Therapeutics, Inc. 6310 Nancy Ridge Dr #101 San Diego CA 92121 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-09-24 | 30,000 | $1.91 | 30,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.90to $1.91, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range setforth above.
- On September 26, 2019, the reporting person filed a Form 4 which inadvertently reported that, following his open market purchase, he held 205,000 shares of the issuer's common stock. In fact, as reported in this amendment, the reporting person directly owned 30,000 shares of common stock.
Billionaire Hedge Funds
